"10.1371_journal.pone.0060103","plos one","2013-03-22T00:00:00Z","Michael Mildner; Stefan Hacker; Thomas Haider; Maria Gschwandtner; Gregor Werba; Caterina Barresi; Matthias Zimmermann; Bahar Golabi; Erwin Tschachler; Hendrik Jan Ankersmit","Department of Dermatology, Medical University Vienna, Vienna, Austria; Department of Plastic Surgery, Medical University Vienna, Vienna, Austria; Christian Doppler Laboratory for Cardiac and Thoracic Diagnosis and Regeneration, Vienna, Austria; Department of Thoracic Surgery, Medical University Vienna, Vienna, Austria; Department of Surgery, Medical University Vienna, Vienna, Austria; Centre de Recherches et dlnvestigations Epidermiques et Sensorielles (CE.R.I.E.S.), Neuilly, France","Conceived and designed the experiments: MM SH ET HJA. Performed the experiments: MM SH TH MG GW CB MZ BG. Analyzed the data: MM SH MG. Wrote the paper: MM SH HJA.","The authors have read the journals policy and have the following conflicts: The Medical University of Vienna has claimed financial interest (Patent number: PCT/EP09/67534, filed 18 Dec 2008; Patent name: PHARMACEUTICAL PREPARATION COMPRISING SUPERNATANT OF BLOOD MONONUCLEAR CELL CULTURE). Hendrik Jan Ankersmit is a shareholder of APOSIENCE AG, which owns the rights to commercialize SECPBMC for therapeutic use. All other authors declare that they have no conflict of interest. APOSIENCE AG is a funder of this study. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","03","Michael Mildner","MM",10,TRUE,4,8,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
